Stockscreener 앱 받기
23.68
4.78%
1.08
시장 영업 전:
20.31
-3.37
-14.23%
Biohaven Ltd 주식(BHVN)의 최신 뉴스
American Century Companies boosts stake in Biohaven, ETF Daily News says - Yahoo Finance
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven LtdBHVN - PR Newswire
Biohaven Ltd. Shares Tumble Amid Market Reassessment - TipRanks
Biohaven Ltd. (NYSE:BHVN) Shares Bought by American Century Companies Inc. - Defense World
Teacher Retirement System of Texas Raises Stake in Biohaven Ltd. (NYSE:BHVN) - Defense World
(BHVN) Proactive Strategies - Stock Traders Daily
Biohaven stock hits 52-week low at $26.7 amid market challenges By Investing.com - Investing.com South Africa
Biohaven stock hits 52-week low at $26.7 amid market challenges - Investing.com India
Biohaven (BHVN) Stock Price, News & Analysis - MarketBeat
Emerald Advisers LLC Acquires New Holdings in Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Focal Epilepsy Market: Analysis of Epidemiology, Pipeline - openPR
Biohaven Ltd. (NYSE:BHVN) Shares Sold by Amundi - Defense World
Major Player in the Multiple System Atrophy (MSA) Market - openPR
Multiple System Atrophy Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma, Ionis Pharma - Barchart
Multiple System Atrophy Market to Reach New Heights in Growth - openPR
Immunovant data positive for Biohaven, says Deutsche Bank - TipRanks
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Shareholders to Learn More About the Investigation - Markets Insider
How To Trade (BHVN) - Stock Traders Daily
Biohaven’s 47% decline validates InvestingPro’s bearish Fair Value call By Investing.com - Investing.com Australia
SEC Form DEF 14A filed by Biohaven Ltd. - Quantisnow
Spinocerebellar Ataxias Pipeline 2025: Therapies, MOA - openPR
Charles Schwab Investment Management Inc. Increases Stock Holdings in Biohaven Ltd. (NYSE:BHVN) - Defense World
Biohaven Ltd. Being Investigated on Behalf of Biohaven Ltd. Investors. Contact Levi & Korsinsky For Details - ACCESS Newswire
US Bancorp DE Raises Stock Position in Biohaven Ltd. (NYSE:BHVN) - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Biohaven Ltd. (BHVN) And Encourages Shareholders to Connect - Markets Insider
Biohaven Ltd. Under Investigation: Levi & Korsinsky Probes Potential Securities Violations - Apna Kal
Investors who lost money on Biohaven Ltd. should contact Levi & Korsinsky about an ongoing investigationBHVN - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Biohaven Ltd. (BHVN) And Encourages Investors to Connect - Markets Insider
Biohaven Ltd. (NYSE:BHVN) Shares Bought by Bank of New York Mellon Corp - Defense World
Unpartnered Obesity Assets Are Becoming Slim Pickings For Pharma - Citeline News & Insights
Bronstein, Gewirtz & Grossman, LLC Encourages Biohaven Ltd. (BHVN) Stockholders to Inquire about Securities Investigation - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Investors to Learn More About the Investigation - Markets Insider
Biohaven Ltd. (NYSE:BHVN) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Biohaven Ltd. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Biohaven Ltd. (BHVN) - ACCESS Newswire
Biohaven Ltd. (BHVN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
ATTENTION Biohaven Ltd. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire
Positive Outlook for Biohaven Ltd. Amid Promising Developments and FDA Priority Review - TipRanks
Independent Director of Biohaven John Childs Buys More Stock - Simply Wall St
Biohaven Ltd. (BHVN): Among Stocks with Heavy Insider Buying in 2025 - Insider Monkey
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
Biohaven Ltd. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsBHVN - ACCESS Newswire
Morgan Stanley Lowers Biohaven (NYSE:BHVN) Price Target to $63.00 - Defense World
How to Take Advantage of moves in (BHVN) - Stock Traders Daily
Empowering women in STEM: Navigating CMC regulatory affairs -March 08, 2025 at 04:31 am EST - Marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Encourages Biohaven Ltd. (BHVN) Investors to Inquire about Securities Investigation - markets.businessinsider.com
Biohaven price target lowered to $63 from $69 at Morgan Stanley - Yahoo Finance
Piper Sandler maintains Biohaven stock with $76 target - Investing.com India
Biohaven Ltd. (NYSE:BHVN) Shares Sold by Private Advisor Group LLC - Defense World
JPMorgan Chase & Co. Lowers Biohaven (NYSE:BHVN) Price Target to $68.00 - Defense World
Biohaven FY2025 EPS Forecast Reduced by Cantor Fitzgerald - Defense World
Morgan Stanley cuts Biohaven stock price target to $63 from $69 By Investing.com - Investing.com South Africa
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Biohaven Ltd. (BHVN) And Encourages Investors to Reach Out - Markets Insider
Morgan Stanley cuts Biohaven stock price target to $63 from $69 - Investing.com India
Optimistic Buy Rating for Biohaven Ltd. Amid Promising Drug Developments and Strategic Pipeline Advancements - TipRanks
Royal Bank of Canada Reaffirms “Outperform” Rating for Biohaven (NYSE:BHVN) - Defense World
HC Wainwright Reiterates Buy Rating for Biohaven (NYSE:BHVN) - Defense World
Director Makes Major Move with Biohaven Ltd. Stock Purchase - TipRanks
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Biohaven Ltd. (BHVN) And Encourages Stockholders to Reach Out - Markets Insider
Biohaven Insider Bought Shares Worth $996,238, According to a Recent SEC Filing -March 05, 2025 at 07:13 am EST - Marketscreener.com
Biohaven director John Childs acquires shares worth $996,238 By Investing.com - Investing.com South Africa
2.00%
자본화:
|
볼륨(24시간):